Aclarion, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ACON research report →
Price Chart
About the company
Aclarion, Inc. , a healthcare technology enterprise based in San Mateo, California, was founded in 2008 and operates within the United States. The company specializes in creating software for magnetic resonance spectroscopy (MRS) applications.
- CEO
- Brent Ness
- IPO
- 2022
- Employees
- 11
- HQ
- Broomfield, CA, US
Get TickerSpark's AI analysis on ACON
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $6.60M
- P/E
- -0.30
- PEG
- -0.00
- P/S
- 78.80
- P/B
- 0.33
- EV/EBITDA
- 1.08
- Div Yield
- 0.00%
- Gross Margin
- -50.96%
- Op Margin
- -11592.14%
- Net Margin
- -10978.48%
- ROE
- -59.34%
- ROIC
- -57.11%
Latest fiscal year · YoY change
- Revenue
- $75.73K+65.6%
- Gross Profit
- $-220,578-162.5%
- Op Income
- $-7,052,391
- Net Income
- $-7,233,629-3.4%
- EPS
- $-13.61+99.8%
- OCF Growth
- -35.9%
- FCF Growth
- -28.5%
- 52W High
- $12.03
- 52W Low
- $1.95
- 50D MA
- $2.45
- 200D MA
- $3.17
- Beta
- 1.21
- RSI (14)
- 42
- Avg Volume
- 53.31K
No earnings-call transcripts are available for ACON yet.
- Free Float
- 70.9%
- Shares Outstanding
- 2.88M
- Float Shares
- 2.04M
of shares held by institutions
10 13F filers
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Bridgeway Capital Management, LLC | 19.48K | ▲ 19.48K |
| Captrust Financial Advisors | 17.06K | ▲ 2.50K |
| Vanguard Fiduciary Trust Co | 16.03K | ▲ 16.03K |
| Susquehanna International Group, Llp | 15.36K | ▲ 15.36K |
| Geode Capital Management, LLC | 12.13K | ▼ 19.09K |
| Xtx Topco Ltd | 11.04K | ▲ 11.04K |
| Bank Of Montreal /Can/ | 10.00K | 0 |
| Vanguard Capital Management LLC | 6.78K | 0 |
| Advisor Group Holdings, Inc. | 5.00K | ▼ 29.95K |
| Ubs Group AG | 1.97K | ▼ 7.68K |
| Barclays PLC | 283 | ▲ 283 |
| Clear Street Group Inc. | 103 | ▲ 100 |
Held by 5 ETFs
Biggest fund positions in ACON by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Aug 17, 26 | Williams Amanda M | buy | 5,857 |
| Aug 14, 26 | Gould Gregory A | buy | 10,000 |
| Aug 13, 26 | Bond Ryan | buy | 21,122 |
| Aug 13, 26 | Wesemann William | buy | 2,150 |
| Aug 13, 26 | Neal David K | buy | 7,500 |
| Aug 13, 26 | Ness Brent | buy | 5,234 |
| Jun 11, 26 | Bond Ryan | other | 55,000 |
| Jun 11, 26 | Sequira Amanda Mae | other | 20,000 |
| Jun 11, 26 | Breidbart Scott | other | 20,000 |
| Jun 11, 26 | Gould Gregory A | other | 50,000 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our ACON coverage
Recent articles, reports, and earnings notes.
No research on ACON yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate ACON report →Aclarion Welcomes NYU Langone Health to CLARITY Trial Network, Now Enrolling at Eleven Sites
prismmediawire.com · Sep 29
Aclarion Welcomes NYU Langone Health to CLARITY Trial Network, Now Enrolling at Eleven Sites
globenewswire.com · Sep 29
Aclarion, Inc. (NASDAQ:ACON) Short Interest Update
defenseworld.net · Sep 28
Reviewing OptimizeRx (NASDAQ:OPRX) & Aclarion (NASDAQ:ACON)
defenseworld.net · Sep 16
Aclarion Announces Addition of University of Arizona College of Medicine – Phoenix as CLARITY Trial Site
prismmediawire.com · Aug 20
Aclarion Announces Addition of University of Arizona College of Medicine – Phoenix as CLARITY Trial Site
globenewswire.com · Aug 20
Aclarion Receives Notice of Allowance for Patent Advancing Accuracy and Adoption of Nociscan's MR Spectroscopy (MRS) Scan Process
prismmediawire.com · Aug 12
Aclarion Receives Notice of Allowance for Patent Advancing Accuracy and Adoption of Nociscan's MR Spectroscopy (MRS) Scan Process
globenewswire.com · Aug 12
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.